Chromadex Market Capitalization from 2010 to 2024

CDXC Stock  USD 1.64  1.34  44.97%   
Chromadex Corp's Market Cap is increasing over the years with slightly volatile fluctuation. Overall, Market Cap is expected to go to about 232.4 M this year.
Check Chromadex Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chromadex Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 863.7 K, Interest Expense of 3.3 K or Selling General Administrative of 16.5 M, as well as many indicators such as Price To Sales Ratio of 1.22, Dividend Yield of 0.0 or PTB Ratio of 3.58. Chromadex financial statements analysis is a perfect complement when working with Chromadex Corp Valuation or Volatility modules.
  
Check out the analysis of Chromadex Corp Correlation against competitors.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.

Latest Chromadex Corp's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Chromadex Corp over the last few years. It is Chromadex Corp's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chromadex Corp's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 225.11 M10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Chromadex Market Capitalization Regression Statistics

Arithmetic Mean178,736,956
Geometric Mean158,792,711
Coefficient Of Variation41.37
Mean Deviation66,570,529
Median221,320,224
Standard Deviation73,941,808
Sample Variance5467.4T
Range208.3M
R-Value0.86
Mean Square Error1499.5T
R-Squared0.75
Significance0.000034
Slope14,274,022
Total Sum of Squares76543.5T

Chromadex Market Capitalization History

2024232.4 M
2023221.3 M
2017245.9 M
2016123.4 M
2012131.3 M
201137.6 M
201065.6 M

About Chromadex Corp Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Chromadex Corp income statement, its balance sheet, and the statement of cash flows. Chromadex Corp investors use historical funamental indicators, such as Chromadex Corp's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Chromadex Corp investors may use each financial statement separately, they are all related. The changes in Chromadex Corp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chromadex Corp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Chromadex Corp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Chromadex Corp. Please read more on our technical analysis and fundamental analysis pages.
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. ChromaDex Corporation is headquartered in Los Angeles, California. Chromadex Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 115 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Chromadex Stock

When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock:
Check out the analysis of Chromadex Corp Correlation against competitors.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.05)
Revenue Per Share
1.108
Quarterly Revenue Growth
(0.02)
Return On Assets
(0.05)
Return On Equity
(0.12)
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.